GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Abingdon Health PLC (LSE:ABDX) » Definitions » Operating Margin %

Abingdon Health (LSE:ABDX) Operating Margin % : -60.75% (As of Dec. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Abingdon Health Operating Margin %?

Operating Margin % is calculated as Operating Income divided by its Revenue. Abingdon Health's Operating Income for the six months ended in Dec. 2023 was £-1.46 Mil. Abingdon Health's Revenue for the six months ended in Dec. 2023 was £2.41 Mil. Therefore, Abingdon Health's Operating Margin % for the quarter that ended in Dec. 2023 was -60.75%.

The historical rank and industry rank for Abingdon Health's Operating Margin % or its related term are showing as below:

LSE:ABDX' s Operating Margin % Range Over the Past 10 Years
Min: -423.74   Med: -61.26   Max: 4.15
Current: -47.29


LSE:ABDX's Operating Margin % is ranked worse than
69.68% of 221 companies
in the Medical Diagnostics & Research industry
Industry Median: -5.51 vs LSE:ABDX: -47.29

Abingdon Health's 5-Year Average Operating Margin % Growth Rate was 0.00% per year.

Abingdon Health's Operating Income for the six months ended in Dec. 2023 was £-1.46 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Dec. 2023 was £-2.53 Mil.

Warning Sign:

Abingdon Health PLC has never been profitable in the past 3 years. It lost money every year.


Abingdon Health Operating Margin % Historical Data

The historical data trend for Abingdon Health's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abingdon Health Operating Margin % Chart

Abingdon Health Annual Data
Trend Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Operating Margin %
Get a 7-Day Free Trial -61.26 4.15 -46.65 -423.74 -88.88

Abingdon Health Semi-Annual Data
Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Operating Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only -322.36 -576.48 -227.90 -36.23 -60.75

Competitive Comparison of Abingdon Health's Operating Margin %

For the Diagnostics & Research subindustry, Abingdon Health's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Abingdon Health's Operating Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Abingdon Health's Operating Margin % distribution charts can be found below:

* The bar in red indicates where Abingdon Health's Operating Margin % falls into.



Abingdon Health Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Abingdon Health's Operating Margin % for the fiscal year that ended in Jun. 2023 is calculated as

Operating Margin %=Operating Income (A: Jun. 2023 ) / Revenue (A: Jun. 2023 )
=-3.595 / 4.045
=-88.88 %

Abingdon Health's Operating Margin % for the quarter that ended in Dec. 2023 is calculated as

Operating Margin %=Operating Income (Q: Dec. 2023 ) / Revenue (Q: Dec. 2023 )
=-1.464 / 2.41
=-60.75 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Abingdon Health  (LSE:ABDX) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Abingdon Health Operating Margin % Related Terms

Thank you for viewing the detailed overview of Abingdon Health's Operating Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Abingdon Health (LSE:ABDX) Business Description

Traded in Other Exchanges
N/A
Address
York Biotech Campus, Sand Hutton, York, GBR, YO41 1LZ
Abingdon Health PLC is a technology-enabled lateral flow diagnostics company. It provides rapid testing solutions to clients in healthcare and other industries. The firm's product ABC-19 is an antibody test for Covid-19 , and also produces tests covering areas such as self-test HIV, equine infection, human fertility, etc. Business operating segments includes; Contract Development comprises development work for third parties. Contract Manufacturing comprises contract development and manufacturing activities. Product Sales comprises the sale of ABC-19, Pocket Diagnostic products, PCRD tests and antibodies for research use. Key revenue comes from Contract Development segment. Geographically it operates and earns revenue from the UK, USA and Canada, Europe and the rest of the world.

Abingdon Health (LSE:ABDX) Headlines

No Headlines